Abbott loses bid to prevent Indian drug-cartel claims being investigated
US drugmaker Abbott has lost a bid to block an investigation into allegations it fixed the price of a diabetes drug with rivals Novartis, Emcure Pharmaceuticals and USV in India. Abbott...To view the full article, register now.
Already a subscriber? Click here to view full article